There was no association between A3A mRNA levels and A3B deletions, but A3B mRNA levels showed a tendency to be lower in breast cancers with A3B deletion (p = 0.299 and 0.075, respectively) (Fig 2). This evidence concerns the gene APOBEC3A and breast carcinoma.